Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis

Trial Profile

Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Bronchitis
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 1 Dec 2017.
    • 12 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Nov 2017.
    • 19 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top